ASX Release 6 November 2026 Nexsen advances kidney diagnostics program Highlights: • RenalSure® targeting FDA submission in mid-2027: Nexsen’s first kidney diagnostic is advancing through development and clinical validation. 1 • 149 million AKI tests annually : Significant repeat-testing...
